SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
14.74
-0.12 (-0.81%)
Last updated: Apr 29, 2026, 10:08 AM CET
ETR:1SXP Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 |
| Market Capitalization | 2,238 | 3,178 | 4,618 | 4,765 | - | - | Upgrade
|
| Market Cap Growth | -34.25% | -31.18% | -3.10% | - | - | - | Upgrade
|
| Enterprise Value | 2,563 | 3,440 | 4,867 | 4,914 | - | - | Upgrade
|
| Last Close Price | 14.86 | 20.84 | 30.07 | 30.91 | - | - | Upgrade
|
| PE Ratio | 15.02 | 21.70 | 30.85 | 31.38 | - | - | Upgrade
|
| Forward PE | 15.30 | 19.36 | 30.23 | - | - | - | Upgrade
|
| PS Ratio | 2.25 | 3.22 | 4.83 | 5.30 | - | - | Upgrade
|
| PB Ratio | 2.40 | 3.56 | 5.86 | 6.89 | - | - | Upgrade
|
| P/TBV Ratio | 2.49 | 3.69 | 6.11 | 7.23 | - | - | Upgrade
|
| P/FCF Ratio | 193.04 | 89.28 | 57.95 | 770.48 | - | - | Upgrade
|
| P/OCF Ratio | 14.14 | 17.66 | 20.55 | 26.23 | - | - | Upgrade
|
| PEG Ratio | 1.80 | 1.71 | 2.66 | - | - | - | Upgrade
|
| EV/Sales Ratio | 2.58 | 3.49 | 5.09 | 5.47 | - | - | Upgrade
|
| EV/EBITDA Ratio | 8.97 | 13.25 | 19.55 | 22.59 | - | - | Upgrade
|
| EV/EBIT Ratio | 12.61 | 18.52 | 25.77 | 28.70 | - | - | Upgrade
|
| EV/FCF Ratio | 221.03 | 96.63 | 61.07 | 794.52 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.37 | 0.34 | 0.36 | 0.30 | 0.28 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 1.28 | 1.14 | 1.13 | 0.94 | 0.92 | 0.67 | Upgrade
|
| Debt / FCF Ratio | 29.93 | 8.51 | 3.59 | 33.92 | 6.49 | 2.95 | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.31 | 0.33 | 0.27 | 0.23 | 0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.22 | 1.07 | 1.04 | 0.85 | 0.78 | 0.48 | Upgrade
|
| Net Debt / FCF Ratio | 27.80 | 7.79 | 3.26 | 29.74 | 5.48 | 2.13 | Upgrade
|
| Asset Turnover | 0.64 | 0.65 | 0.72 | 0.74 | 0.85 | 0.97 | Upgrade
|
| Inventory Turnover | 3.94 | 4.07 | 4.45 | 4.35 | 4.94 | 5.76 | Upgrade
|
| Quick Ratio | 0.70 | 0.75 | 0.66 | 0.80 | 0.80 | 0.80 | Upgrade
|
| Current Ratio | 1.58 | 1.50 | 1.34 | 1.33 | 1.72 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 17.06% | 17.47% | 20.31% | 21.69% | 22.30% | 27.53% | Upgrade
|
| Return on Assets (ROA) | 7.57% | 7.65% | 8.84% | 8.81% | 10.85% | 10.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.09% | 13.10% | 16.04% | 16.00% | 19.55% | 21.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.90% | 16.20% | 18.80% | 19.40% | 19.20% | 23.10% | Upgrade
|
| Earnings Yield | 6.70% | 4.61% | 3.24% | 3.19% | - | - | Upgrade
|
| FCF Yield | 0.52% | 1.12% | 1.73% | 0.13% | - | - | Upgrade
|
| Dividend Yield | 1.20% | 0.86% | 0.53% | 0.48% | - | - | Upgrade
|
| Payout Ratio | 16.07% | 16.45% | 15.09% | 12.43% | 9.14% | 39.53% | Upgrade
|
| Buyback Yield / Dilution | -1.18% | - | - | - | 0.00% | - | Upgrade
|
| Total Shareholder Return | 0.01% | 0.86% | 0.53% | 0.48% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.